Which REM Sleep Behavior Disorder Patients Will Develop Parkinson's? CND Works on Skin Biopsy Test for Early Detection of Synucleinopathies
CND Life Sciences is studying its Syn-One Test in hopes of predicting the conversion of RBD to a more advanced synucleinopathy.
United States Mitchell Miglis Todd Levine American Prodromal Synucleinopathy Consortium Stroke Of The National Institutes Health Phase Ii Small Business Innovation Research
Source: sleepreviewmag.com